Beta
Clomipramine
medication Under reviewA tricyclic antidepressant medication used to treat obsessive-compulsive disorder and other conditions.
Research summary
The human evidence base for clomipramine is strongest for obsessive-compulsive disorder, where it has long been shown to reduce obsessive and compulsive symptoms and remains a well-established treatment option. Reviews and clinical summaries also describe benefit in some other psychiatric or pain-related conditions, but those uses are generally off-label and less consistently supported. Research and labeling also show that clomipramine can cause clinically important adverse effects, including sedation, anticholinergic effects, weight gain, sexual dysfunction, and cardiovascular or seizure-related risks. Overall, the evidence supports clomipramine as an effective prescription drug for specific indications, but not as a health supplement.
Reported Benefits
No reports yet
Be the first to report this effect and help the community.
Add Clomipramine to your stack to report effects
Screening the Combination of Gemcitabine, Clomipramine, and Resveratrol in HL-60 Leukemia Cells.
Molden E, Spigset O, and colleagues
Palliative psychiatry and euthanasia in refractory obsessive-compulsive disorder: A case report.
Health.mil
Clomipramine. An overview of its pharmacological properties and a review of its therapeutic use in obsessive compulsive disorder and panic disorder.
Bremner JD
Clomipramine in the treatment of patients with obsessive-compulsive disorder. The Clomipramine Collaborative Study Group.
PubMed record
No reports yet
Be the first to report this effect and help the community.
Add Clomipramine to your stack to report effects
Screening the Combination of Gemcitabine, Clomipramine, and Resveratrol in HL-60 Leukemia Cells.
Molden E, Spigset O, and colleagues
Palliative psychiatry and euthanasia in refractory obsessive-compulsive disorder: A case report.
Health.mil
No reports yet
Be the first to report this effect and help the community.
Add Clomipramine to your stack to report effects
Screening the Combination of Gemcitabine, Clomipramine, and Resveratrol in HL-60 Leukemia Cells.
Molden E, Spigset O, and colleagues
No reports yet
Be the first to report this effect and help the community.
Add Clomipramine to your stack to report effects
Screening the Combination of Gemcitabine, Clomipramine, and Resveratrol in HL-60 Leukemia Cells.
Molden E, Spigset O, and colleagues
Reported Side Effects
No reports yet
Be the first to report this effect and help the community.
Add Clomipramine to your stack to report effects
Anafranil (clomipramine hydrochloride) prescribing information
U.S. Food and Drug Administration
Screening the Combination of Gemcitabine, Clomipramine, and Resveratrol in HL-60 Leukemia Cells.
Molden E, Spigset O, and colleagues
No reports yet
Be the first to report this effect and help the community.
Add Clomipramine to your stack to report effects
Anafranil (clomipramine hydrochloride) prescribing information
U.S. Food and Drug Administration
Screening the Combination of Gemcitabine, Clomipramine, and Resveratrol in HL-60 Leukemia Cells.
Molden E, Spigset O, and colleagues
No reports yet
Be the first to report this effect and help the community.
Add Clomipramine to your stack to report effects
Anafranil (clomipramine hydrochloride) prescribing information
U.S. Food and Drug Administration
Screening the Combination of Gemcitabine, Clomipramine, and Resveratrol in HL-60 Leukemia Cells.
Molden E, Spigset O, and colleagues
No reports yet
Be the first to report this effect and help the community.
Add Clomipramine to your stack to report effects
Anafranil (clomipramine hydrochloride) prescribing information
U.S. Food and Drug Administration
Screening the Combination of Gemcitabine, Clomipramine, and Resveratrol in HL-60 Leukemia Cells.
Molden E, Spigset O, and colleagues
No reports yet
Be the first to report this effect and help the community.
Add Clomipramine to your stack to report effects
Anafranil (clomipramine hydrochloride) prescribing information
U.S. Food and Drug Administration
Screening the Combination of Gemcitabine, Clomipramine, and Resveratrol in HL-60 Leukemia Cells.
Molden E, Spigset O, and colleagues
No reports yet
Be the first to report this effect and help the community.
Add Clomipramine to your stack to report effects
Anafranil (clomipramine hydrochloride) prescribing information
U.S. Food and Drug Administration
Screening the Combination of Gemcitabine, Clomipramine, and Resveratrol in HL-60 Leukemia Cells.
Molden E, Spigset O, and colleagues
Related health conditions
Research showing how this habit affects specific health conditions. Always consult healthcare professionals.
May Help With
Major depressive disorder or persistent depressive symptoms
Screening the Combination of Gemcitabine, Clomipramine, and Resveratrol in HL-60 Leukemia Cells.
Molden E, Spigset O, and colleagues
Difficulty falling asleep, staying asleep, or waking too early
Screening the Combination of Gemcitabine, Clomipramine, and Resveratrol in HL-60 Leukemia Cells.
Molden E, Spigset O, and colleagues
Generalized anxiety disorder or anxiety symptoms affecting daily life
Screening the Combination of Gemcitabine, Clomipramine, and Resveratrol in HL-60 Leukemia Cells.
Molden E, Spigset O, and colleagues
Palliative psychiatry and euthanasia in refractory obsessive-compulsive disorder: A case report.
Health.mil
Research (5 studies)
Screening the Combination of Gemcitabine, Clomipramine, and Resveratrol in HL-60 Leukemia Cells.
Molden E, Spigset O, and colleagues
Palliative psychiatry and euthanasia in refractory obsessive-compulsive disorder: A case report.
Health.mil
Anafranil (clomipramine hydrochloride) prescribing information
U.S. Food and Drug Administration
Clomipramine in the treatment of patients with obsessive-compulsive disorder. The Clomipramine Collaborative Study Group.
PubMed record
Clomipramine. An overview of its pharmacological properties and a review of its therapeutic use in obsessive compulsive disorder and panic disorder.
Bremner JD
Community updates
No updates yet for this supplement.
Be the first to share your experience!